Context Therapeutics
CNTX · NASDAQ
$0.2438+$0.0054 (+2.27%)TodayMarket closed ·
Prev close $0.2384
Who owns CNTX
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 52.7% of CNTX’s shares.
- Nextech Invest, Ltd.8.1%
- Deep Track Capital LP8.1%
- Soleus Capital Management, L.P.7.7%
- BlackRock Institutional Trust Company, N.A.6.1%
- Next 6 largest institutions22.7%
- All other shareholders47.3%
| Holder | Shares | % of shares |
|---|---|---|
| Nextech Invest, Ltd. | 7.42M | 8.08% |
| Deep Track Capital LP | 7.42M | 8.08% |
| Soleus Capital Management, L.P. | 7.06M | 7.69% |
| BlackRock Institutional Trust Company, N.A. | 5.62M | 6.11% |
| Avidity Partners Management LP | 5.00M | 5.44% |
| Franklin Advisers, Inc. | 3.80M | 4.14% |
| Vanguard Capital Management, LLC | 3.43M | 3.74% |
| Octagon Capital Advisors LP | 3.05M | 3.32% |
| Blue Owl Capital Holdings LP | 2.93M | 3.19% |
| TCG Crossover Management, LLC | 2.68M | 2.92% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.82M | 3.06% |
| Franklin Templeton Investment Funds -Biotechnology Discovery | 2.40M | 2.62% |
| iShares Russell 2000 ETF | 2.32M | 2.52% |
| Franklin Biotechnology Discovery Fund | 1.40M | 1.52% |
| Fidelity Small Cap Index Fund | 1.01M | 1.10% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of CNTX in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Kantoff Philip W. | Award | 45.00K | — |
| West Linda | Award | 45.00K | — |
| Pasternak Andy | Award | 45.00K | — |
| Walker Luke Nathaniel | Award | 45.00K | — |
| Smith Karen L. | Award | 45.00K | — |
| Stacey Jennifer Evans | Award | 45.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 4.71M
- Days to cover
- 4.03
- % of shares outstanding
- 5.12%
- Average daily volume
- 1.17M
- Change since last report
- −31.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.